• Your Selections:

Refine Results

date

Topics

Content Type

Tags

Ending the HIV Epidemic (EHE) Funding Tracker

This tracker provides up-to-date data on federal Ending the HIV Epidemic (EHE( funding, including an overview of funding mechanisms by year, agency, grant mechanism, and jurisdiction. It will be updated over time.

Women and HIV in the United States

This updated fact sheet highlights the impact of HIV/AIDS on women in the United States, providing current data and trends over time.

Sexually Transmitted Infections (STIs): An Overview, Payment, and Coverage

More people have health insurance than ever before under the Affordable Care Act (ACA), which emphasizes preventive care, including no-cost HIV and STI counseling and screening for recommended populations. This fact sheet examines trends and disparities in STI prevalence, reviews the STI screening and preventive care coverage policies for private insurance and public programs, and discusses coverage gaps and confidentiality concerns in the provision of these services.

Black Americans and HIV/AIDS: The Basics

This updated fact sheet highlights the epidemic’s impact on Black Americans, providing current data and trends over time. Black Americans have been disproportionately affected by HIV/AIDS since the epidemic’s beginning, and that disparity has deepened over time. Black Americans account for more new HIV diagnoses, people estimated to be living with HIV, and HIV-related deaths than any other racial/ethnic group in the U.S.

Medicaid Work Requirements and People with HIV

This data note examines the potential implications of work requirements for people with HIV, a population that relies heavily on Medicaid and for whom there are important clinical and public health reasons for maintaining consistent access to insurance coverage and HIV care.

Quick Look: Antiretroviral Price Increases in Medicare Part D

Drug price concerns in the U.S., including for antiretrovirals, the mainstay of HIV treatment and, increasingly prevention, have prompted the introduction of several policy proposals. One proposal would require manufacturers to provide a rebate to the federal government if prices increase faster than inflation. We assessed list price changes for ARVs under Part D, which is required to cover all or substantially all ARVs.